Skip to main content
Yifeng Pharmacy Chain Co., Ltd. logo

Yifeng Pharmacy Chain Co., Ltd. — Investor Relations & Filings

Ticker · 603939 ISIN · CNE100001TS5 LEI · 300300CZZIF44N1EZO06 Shanghai Stock Exchange Wholesale and retail trade
Open in API
Filings indexed 1,865 across all filing types
Latest filing 2023-07-14 Capital/Financing Update
Country CN China
Listing Shanghai Stock Exchange 603939

About Yifeng Pharmacy Chain Co., Ltd.

https://www.yfdyf.cn/

Yifeng Pharmacy Chain Co., Ltd. operates as a large-scale retail pharmacy enterprise. The company specializes in the distribution and sale of prescription drugs, over-the-counter medicines, traditional Chinese medicine, nutritional supplements, and medical devices. It utilizes a standardized management system across its extensive network of retail stores to ensure service quality and operational efficiency. Beyond physical retail, the company has developed a comprehensive digital healthcare ecosystem, integrating online-to-offline (O2O) services to provide professional pharmaceutical consultations and health management solutions. Its business model focuses on a "big health" strategy, aiming to provide accessible healthcare products and professional services to a broad consumer base through optimized supply chain logistics and a diversified product portfolio.

Recent filings

Filing Released Lang Actions
湖南启元律师事务所关于益丰大药房连锁股份有限公司向不特定对象发行可转换公司债券的补充法律意见书（五）
Capital/Financing Update Classification · 95% confidence The document is a legal opinion letter issued by a law firm (湖南启元律师事务所) regarding the issuance of convertible bonds by 益丰大药房连锁股份有限公司. It includes detailed legal analysis, regulatory compliance checks, and responses to inquiries from the China Securities Regulatory Commission and the Shanghai Stock Exchange. The document is titled as a "补充法律意见书（五）" (Supplementary Legal Opinion Letter No. 5) and focuses on legal due diligence and compliance related to the convertible bond issuance. It is not a financial report, earnings release, or management discussion, but a legal advisory document related to capital raising. Therefore, it fits best under the category of Capital/Financing Update (CAP). The document length (8470 characters) and content confirm it is a substantive legal opinion, not a brief announcement or certification, so it is not RNS or RPA.
2023-07-14 Chinese
内部控制制度
Governance Information Classification · 95% confidence The document is titled '内部控制制度' (Internal Control System) and details the internal control policies, governance structure, risk assessment, control activities, information and communication, and internal supervision of the company. It is a comprehensive internal control manual or policy document issued by the company's board of directors. There is no indication that this is an annual report, audit report, or financial statement. It is not a meeting presentation, voting result, or legal proceeding. The document is a governance-related report detailing internal rules, control environment, and governance practices. Therefore, it fits best under Governance Information (CGR). The document length is over 5,000 characters and contains substantive content, not just an announcement or certification, so it is not RPA or RNS.
2023-07-14 Chinese
董事会秘书工作细则
Governance Information Classification · 95% confidence The document is titled as '董事会秘书工作细则' which translates to 'Board Secretary Work Rules' or 'Board Secretary Working Procedures'. It details the roles, qualifications, responsibilities, appointment, dismissal, and legal liabilities of the board secretary. The content is about governance practices and internal rules related to the board secretary's function within the company. There is no financial data, no report of financial results, no announcement of voting results, no legal proceedings, no capital changes, no earnings information, and no mention of any report publication or regulatory filing. The document is a governance-related internal regulation document. Therefore, the most appropriate classification is Governance Information (CGR). The document length is 3127 characters, which is relatively short but contains substantive governance content, not just an announcement or notice.
2023-07-14 Chinese
关于益丰大药房连锁股份有限公司向不特定对象发行可转换公司债券的审核中心意见落实函的回复报告
Regulatory Filings Classification · 95% confidence The document is a detailed reply report from a company and its sponsor (underwriter) addressing regulatory inquiries related to the issuance of convertible bonds. It includes extensive explanations about administrative penalties, compliance measures, and legal opinions. The document references a specific regulatory review by the Shanghai Stock Exchange and discusses the company's response to audit center opinions regarding the issuance of convertible bonds. It is not a full annual or interim financial report, nor is it a simple announcement or certification. The content is focused on regulatory compliance and the company's corrective actions in response to regulatory scrutiny, which aligns with a Regulatory Filings (RNS) classification as it does not fit neatly into other categories like Capital/Financing Update (CAP) or Audit Report (AR). The document length and detail also suggest it is not merely a report publication announcement (RPA).
2023-07-14 Chinese
益丰药房2023年第二次临时股东大会会议资料
AGM Information Classification · 95% confidence The document is titled as meeting materials for the "2023 Second Extraordinary General Meeting" of the company. It includes the meeting agenda, voting procedures, and a specific proposal regarding amendments to the company's articles of association and related capital changes. The content is focused on the meeting itself, including procedural details and the agenda for shareholder voting. The document length is 3514 characters, which is relatively short and consistent with meeting materials rather than a full report. There is no financial statement or detailed financial analysis present, so it is not an Annual Report (10-K) or Interim Report (IR). It is not a voting results announcement (DVA) because it does not provide the results, only the meeting materials. It is not a Proxy Solicitation (PSI) because it is not explicitly soliciting votes but providing meeting information and agenda. The best fit is AGM Information (AGM-R), which covers presentations and materials shared during the Annual General Meeting or Extraordinary General Meeting. Therefore, the document is classified as AGM Information (AGM-R) with high confidence.
2023-07-11 Chinese
益丰药房关于调整回购注销部分限制性股票数量与价格的公告
Transaction in Own Shares Classification · 100% confidence The document is an announcement from a company about adjusting the quantity and price of repurchased and canceled restricted stocks. It details board and supervisory meetings, legal opinions, and compliance with stock incentive plans and regulations. The content focuses on share repurchase and cancellation of restricted shares, including adjustments due to dividends and stock splits. There are no financial statements or comprehensive financial data presented, nor is this a report or presentation. The document is a formal announcement regarding a transaction in the company's own shares (repurchase and cancellation). Therefore, the appropriate classification is 'Transaction in Own Shares' (POS). The document length is 3360 characters, which is consistent with an announcement rather than a full report.
2023-06-29 Chinese

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.